MUC16 and ovarian cancer: The diagnostic utility of sEVs-based biosensors, specifically the sEVs/CA125 ratio, has shown superior diagnostic value compared to CA125 or sEVs alone in detecting stage I disease, significantly enhances the diagnostic efficiency for ovarian cancer (66).